Clinical Trials Related to Lirafugratinib

Related studies linked through entity extraction aliases.

A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement

Status: RECRUITING
Phase: PHASE2